Back to results
US 5,010,104 AGranted
Tricyclic compounds
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsEtsuo Oshima, Hiroyuki Obase, Akira Karasawa, Kazuhiro Kubo, Ichiro Miki, Akio Ishii
Life of this patent
Estimating the term…
Abstract
Novel tricyclic compounds having a TXA.sub.2 -antagonizing activity represented by formul (I): ##STR1## which strongly antagonize an action of thromboxane A.sub.2 and are expected to have preventive and therapeutic effects on ischemica diseases, cerebro-vascular diseases, etc.
Claims11
A tricyclic compound represented by the formula:
- ##STR144## wherein:
- X.sub.1 -X.sub.2 is selected from the group consisting of --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--;
- L is --CH.dbd.CH--;
- ------ is a single or double bond;
- W is selected from the group consisting of --S--, --CH.sub.2 --, or .dbd.CH--, and the left side of each formula is bound to the tricyclic nucleus;
- n is 0,1,2 or 3;
- Z is selected from the group consisting of --NR.sup.1 CO--, --NR.sup.1 SO.sub.2 -- --NR.sup.1 CONH--, --NR.sup.1 CSNH--, --NR.sup.1 NHCONH--, --NR.sup.1 NHCSNH--, --NR.sup.1 COO-- or --NR.sup.1 COS--, wherein R.sup.1 is hydrogen or lower alkyl, and the right side of each formula is bound to Q;
- Q is selected from the group consisting of straight of branched alkyl having 1 to 18 carbon atoms, alicyclic alkyl having 3 to 6 carbon atoms, lower alkenyl having 2 to 6 carbon atoms and optionally substituted carbocyclic aryl, optionally substituted aralkyl, aralkenyl, furyl, thienyl, or coumarinyl wherein substitution means 1 to 3 substituents on the aromatic ring, independently selected from lower alkyl, phenyl, benzyl, halogen, triflouromethyl, nitro, OR.sup.2 and SR.sup.2, wherein R.sup.2 represents hydrogen, lower alkyl, phenyl or benzyl;
- one of R.sup.A and R.sup.B is hydrogen and the other is --Y--M-- wherein Y is selected from the group consisting of single bond, --CR.sup.3 R.sup.4 --(CH.sub.2).sub.m -- and --CR.sup.3 .dbd.CR.sup.4 --(CH.sup.2).sub.m)-- and each of R.sup.3 and R.sup.4 are independently hydrogen or lower alkyl and m is 0, 1, 2, 3, or 4, wherein the left side of each formula is bond to the tricyclic nucleus;
- M is --COOR.sup.5 and R.sup.5 is hydrogen or lower alkyl;
- each of G.sup.A and G.sup.B are independently lower alkyl, halogen or OR.sup.6 and R.sup.6 represents hydrogen, lower alkyl, phenyl or benzyl;
- each of g.sup.A and g.sup.B are independently 0, 1, 2 or 3;
- or a pharmaceutically acceptable salt thereof.
10 more elements
Dependencies are inferred from the claim text.